Balice-Gordon Rita J.
SEC CIK 1825625 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| COLL | COLLEGIUM PHARMACEUTICAL, INC | Dir | 61.4K | — | $171.7K | 6 | 2022-05-19 | 2026-05-14 |
Most active insiders at COLL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Dreyer Scott | EVP, Chief Commercial Off | — | $2.87M |
| 2 | Fallon John A. | Dir | — | $1.65M |
| 3 | Tupper Colleen | EVP, CFO | — | $1.22M |
| 4 | Dieter David | EVP, GC | — | $716.2K |
| 5 | BOHLIN GAREN G | Dir | — | $323.5K |
| 6 | Balice-Gordon Rita J. | Dir | — | $171.7K |
| 7 | Lurker Nancy | Dir | — | $161.9K |
| 8 | Freund John Gordon | Dir | — | $143.2K |
| 9 | Glancy Donovan Michael | Dir | — | — |
| 10 | Smith Thomas B | EVP, Chief Medical Off | — | — |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-18 16:15 | 2026-05-14 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Balice-Gordon Rita J. | Dir | A - Grant | $0.00 | +8,741 | 61.4K | +17% | $0 | |
| 2025-12-09 | 2025-12-05 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Balice-Gordon Rita J. | Dir | S - Sale | $47.03 | -3,650 | 52.6K | -6% | -$171.7K | |
| 2025-05-19 | 2025-05-15 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Balice-Gordon Rita J. | Dir | A - Grant | $0.00 | +9,791 | 56.3K | +21% | $0 | |
| 2024-05-16 | 2024-05-16 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Balice-Gordon Rita J. | Dir | A - Grant | $0.00 | +7,693 | 46.5K | +20% | $0 | |
| 2023-05-19 | 2023-05-18 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Balice-Gordon Rita J. | Dir | A - Grant | $0.00 | +9,792 | 38.8K | +34% | $0 | |
| 2022-05-23 | 2022-05-19 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Balice-Gordon Rita J. | Dir | A - Grant | $0.00 | +14.0K | 29.0K | +94% | $0 |
Purchase Sale Sale after option exercise All abbreviations